Trial Profile
Phase I trial of RO5323441 combined with bevacizumab in patients with recurrent glioblastoma.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Jul 2017
Price :
$35
*
At a glance
- Drugs THR 317 (Primary) ; Bevacizumab
- Indications Glioblastoma
- Focus Adverse reactions; Pharmacokinetics
- 04 Apr 2016 New trial record